Company delivers next-generation biomarkers as a basis for decision support in precision medicine. We use novel, state of the art, machine learning approaches specifically designed to find complex patterns in biomedical data.
Technology: Early drug development
Industry: Biomarker Development
Headquarters: EU
Founded Date: 2017

Visit Website
Register and Claim Ownership